Stay updated on Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2 from the page.
    Difference
    0.0%
    Check dated 2026-03-11T16:28:12.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page history now includes an addition of Revision: v3.4.2 and deletions of a government-funding notice and Revision: v3.4.1, which are UI/versioning updates rather than changes to trial data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T06:17:55.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a site-wide funding and operating status notice and updated the revision to v3.4.1, removing the previous v3.4.0 revision. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T05:15:14.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The history page adds a glossary toggle and legends for color-coded changes (green for additions, red for deletions) and updates the revision label to v3.4.0.
    Difference
    0.4%
    Check dated 2026-01-28T02:47:43.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The history page now shows Revision: v3.3.4 in place of Revision: v3.3.3. This is a minor site version update.
    Difference
    0.0%
    Check dated 2026-01-14T00:41:57.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.3.3, and the HHS Vulnerability Disclosure item as well as the Revision: v3.3.2 note were removed. These changes are metadata updates and do not affect the study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T08:58:29.000Z thumbnail image

Stay in the know with updates to Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial page.